Arrivent Biopharma, Common Stock Price History

AVBP Stock   20.01  0.49  2.51%   
If you're considering investing in ArriVent Stock, it is important to understand the factors that can impact its price. As of today, the current price of ArriVent BioPharma, stands at 20.01, as last reported on the 24th of March, with the highest price reaching 20.38 and the lowest price hitting 18.90 during the day. ArriVent BioPharma, secures Sharpe Ratio (or Efficiency) of -0.17, which signifies that the company had a -0.17 % return per unit of risk over the last 3 months. ArriVent BioPharma, Common exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ArriVent BioPharma,'s Risk Adjusted Performance of (0.13), standard deviation of 2.83, and Mean Deviation of 2.14 to double-check the risk estimate we provide.
  
At this time, ArriVent BioPharma,'s Other Stockholder Equity is relatively stable compared to the past year. As of 03/24/2025, Common Stock is likely to grow to 2,933, while Liabilities And Stockholders Equity is likely to drop slightly above 182.6 M. . At this time, ArriVent BioPharma,'s Price Book Value Ratio is relatively stable compared to the past year. As of 03/24/2025, Price To Book Ratio is likely to grow to 8.91, while Price To Operating Cash Flows Ratio is likely to drop (10.82). ArriVent Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1652

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsAVBP

Estimated Market Risk

 2.88
  actual daily
25
75% of assets are more volatile

Expected Return

 -0.48
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.17
  actual daily
0
Most of other assets perform better
Based on monthly moving average ArriVent BioPharma, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ArriVent BioPharma, by adding ArriVent BioPharma, to a well-diversified portfolio.
Price Book
2.5771
Book Value
7.644
Enterprise Value
445.3 M
Shares Float
15.8 M
Shares Outstanding
34 M

ArriVent BioPharma, Stock Price History Chart

There are several ways to analyze ArriVent Stock price data. The simplest method is using a basic ArriVent candlestick price chart, which shows ArriVent BioPharma, price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 5, 202529.25
Lowest PriceMarch 18, 202519.5

ArriVent BioPharma, March 24, 2025 Stock Price Synopsis

Various analyses of ArriVent BioPharma,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ArriVent Stock. It can be used to describe the percentage change in the price of ArriVent BioPharma, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ArriVent Stock.
ArriVent BioPharma, Price Daily Balance Of Power 0.33 
ArriVent BioPharma, Price Rate Of Daily Change 1.03 
ArriVent BioPharma, Price Action Indicator 0.62 

ArriVent BioPharma, March 24, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in ArriVent Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use ArriVent BioPharma, intraday prices and daily technical indicators to check the level of noise trading in ArriVent Stock and then apply it to test your longer-term investment strategies against ArriVent.

ArriVent Stock Price History Data

The price series of ArriVent BioPharma, for the period between Tue, Dec 24, 2024 and Mon, Mar 24, 2025 has a statistical range of 9.75 with a coefficient of variation of 10.28. The prices are distributed with arithmetic mean of 25.36. The median price for the last 90 days is 26.21.
OpenHighLowCloseVolume
03/24/2025
 19.52  20.38  18.90  20.01 
03/24/2025
 19.52  20.38  18.90  20.01 
03/21/2025 19.31  20.38  18.90  19.52  364,031 
03/20/2025 20.19  20.19  19.48  19.54  126,408 
03/19/2025 19.36  19.77  19.16  19.60  119,184 
03/18/2025 20.43  20.43  19.49  19.50  113,427 
03/17/2025 21.40  21.65  20.20  20.56  303,922 
03/14/2025 21.89  22.18  20.98  21.00  300,920 
03/13/2025 22.45  22.45  21.50  21.75  87,693 
03/12/2025 22.56  22.75  21.98  22.45  153,960 
03/11/2025 21.73  22.56  21.44  22.48  208,500 
03/10/2025 22.11  22.16  21.46  21.73  112,059 
03/07/2025 21.91  22.24  21.34  21.87  152,844 
03/06/2025 22.65  22.79  21.61  21.81  190,700 
03/05/2025 22.92  22.92  21.98  22.47  154,373 
03/04/2025 21.67  22.45  21.21  21.96  210,589 
03/03/2025 23.55  23.65  21.92  22.03  369,900 
02/28/2025 23.93  24.11  23.17  23.61  211,247 
02/27/2025 24.91  25.23  23.54  23.70  104,855 
02/26/2025 25.23  26.33  23.29  24.38  188,552 
02/25/2025 25.32  26.29  24.72  25.23  203,748 
02/24/2025 26.97  27.85  25.02  25.26  202,400 
02/21/2025 27.12  27.84  26.61  27.07  238,000 
02/20/2025 27.32  28.12  26.93  27.39  101,796 
02/19/2025 25.97  27.93  25.97  27.11  126,228 
02/18/2025 26.70  28.00  25.89  26.21  115,001 
02/14/2025 27.06  27.21  26.44  26.60  111,623 
02/13/2025 27.45  27.45  26.66  26.85  68,305 
02/12/2025 26.32  27.14  26.10  26.90  91,800 
02/11/2025 26.57  27.07  26.57  26.90  110,300 
02/10/2025 26.84  27.17  26.04  26.91  119,915 
02/07/2025 26.98  27.38  25.80  26.09  315,270 
02/06/2025 29.24  29.57  27.33  27.38  85,060 
02/05/2025 27.66  29.31  27.66  29.25  263,314 
02/04/2025 27.38  28.54  26.98  28.20  137,800 
02/03/2025 27.76  28.89  25.90  27.56  174,200 
01/31/2025 29.06  29.71  28.35  28.54  121,100 
01/30/2025 29.40  29.68  28.48  29.09  136,800 
01/29/2025 28.51  29.60  28.50  29.02  129,000 
01/28/2025 28.10  28.98  28.05  28.80  214,100 
01/27/2025 27.12  28.35  26.79  28.24  226,300 
01/24/2025 26.99  27.93  26.41  27.30  96,500 
01/23/2025 26.34  27.70  26.32  27.25  136,000 
01/22/2025 25.90  27.10  25.90  26.63  187,700 
01/21/2025 24.42  26.15  24.42  25.31  127,500 
01/17/2025 24.69  25.49  23.84  24.41  107,600 
01/16/2025 24.12  24.73  23.63  24.48  105,800 
01/15/2025 25.46  26.54  24.69  24.92  159,100 
01/14/2025 25.48  25.77  24.13  24.85  142,500 
01/13/2025 24.71  25.54  23.80  25.42  100,300 
01/10/2025 26.23  27.11  23.97  24.88  238,200 
01/08/2025 26.78  27.34  26.30  26.86  143,800 
01/07/2025 26.06  26.93  25.68  26.84  90,300 
01/06/2025 27.31  27.31  25.76  26.15  106,600 
01/03/2025 27.83  28.51  26.79  27.52  115,200 
01/02/2025 27.09  27.81  26.80  27.47  151,100 
12/31/2024 27.18  27.22  26.36  26.64  87,600 
12/30/2024 27.07  27.50  26.39  26.95  179,100 
12/27/2024 27.46  27.67  26.71  27.26  141,500 
12/26/2024 26.47  27.62  26.22  27.58  70,100 
12/24/2024 26.05  26.63  25.54  26.63  73,600 

About ArriVent BioPharma, Stock history

ArriVent BioPharma, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ArriVent is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ArriVent BioPharma, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ArriVent BioPharma, stock prices may prove useful in developing a viable investing in ArriVent BioPharma,
Last ReportedProjected for Next Year
Common Stock Shares Outstanding30.3 M26.5 M

ArriVent BioPharma, Quarterly Net Working Capital

209.71 Million

ArriVent BioPharma, Stock Technical Analysis

ArriVent BioPharma, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ArriVent BioPharma, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ArriVent BioPharma, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Volatility Now

   

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Module

ArriVent BioPharma, Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for ArriVent BioPharma,'s price direction in advance. Along with the technical and fundamental analysis of ArriVent Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ArriVent to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for ArriVent Stock Analysis

When running ArriVent BioPharma,'s price analysis, check to measure ArriVent BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ArriVent BioPharma, is operating at the current time. Most of ArriVent BioPharma,'s value examination focuses on studying past and present price action to predict the probability of ArriVent BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ArriVent BioPharma,'s price. Additionally, you may evaluate how the addition of ArriVent BioPharma, to your portfolios can decrease your overall portfolio volatility.